Band 6+: The chart below shows how much money five big practical companies spent on research in 2012 and 2018 and gives an estimate of their amounts spent in 2022 describe the data providing an overview of the general trance reporting the main features and making comparisons write at least 150 words

The given bar chart displays the amount of money spent on research field by five big pharmacy companies in 2012 and 2018, as well as provides approximate charge for 2022. Overall, all the companies had more research spendings in 2018, comparing to 2012 and these numbers are expected to rise.

At first glance, it is clearly seen that there was an upward tendency for all the companies. The Pharm had the most insignificant change, because they spent only about 3 additional units of money in 2018. Conversely, the Novas and the Biopharm research founding skyrocketed, as they gave almost five times more money units in 2018 in comperesant with 2012. Lastly, the Fleming’s spending for research doubled and the Avicenna’s ones trippled in 6 years.

In 2022 the Novas is predicted to touch the highest point in research foundings, as their will spend more than 55 money units. Almost half as much will spend the Fleming with 30 units. The other three companies will have precisely identical spendings, reaching no more than 25 money units.